PI3K-activated Akt could inactivate GSK-3β followed by multiple downstream effects; thus, we proposed the hypothesis that Chr-A may inhibit glioblastoma through the Akt/GSK-3β/β-catenin pathway. This evidence concerns the gene AKT1 and glioblastoma.